News | October 13, 2023
Shilpa Medicare launches 'Oraal’ for treatment of oral mucositis
The composition of ORAAL is protected by a granted patent in India until November 2033
The composition of ORAAL is protected by a granted patent in India until November 2033
The products will be manufactured at the company's facility in Bengaluru
The cognitively operated system is a mother patent invention, first launched in India
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
Shilpa Medicare Limited is the first company to receive approval for Manufacturing & Market of Pemetrexed Injection 10 ml, 50 ml, 85 ml, and 100 ml in India
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
The 'A+' rating reflects IOL's robust business model, diversified product portfolio
As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
Subscribe To Our Newsletter & Stay Updated
